HMG-CoA Reductase Inhibitor [EPC]

298160 reported adverse events

Drugs of this class: SIMVASTATIN LOVASTATIN EZETIMIBE AND SIMVASTATIN ATORVASTATIN CALCIUM PITAVASTATIN MAGNESIUM ROSUVASTATIN

These side effects are most commonly reported by patients taking drugs of the HMG-CoA Reductase Inhibitor [EPC] class:

# Side effect Count
0 FATIGUE 15471
1 NAUSEA 14941
2 DRUG INEFFECTIVE 14616
3 DYSPNOEA 14220
4 DIARRHOEA 13076
5 DIZZINESS 12647
6 ASTHENIA 10752
7 PAIN 10455
8 MYALGIA 10310
9 FALL 10219
See all common reactions for HMG-CoA Reductase Inhibitor [EPC]

Drugs of the HMG-CoA Reductase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IMMUNE-MEDIATED NECROTISING MYOPATHY 257 0.4597
1 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 181 0.2604
2 MYOPATHY 1533 0.2592
3 HYPERPARATHYROIDISM SECONDARY 421 0.2320
4 RHABDOMYOLYSIS 6593 0.2260
5 NEPHROGENIC ANAEMIA 763 0.2224
6 REBOUND ACID HYPERSECRETION 455 0.1730
7 MYOSITIS 834 0.1540
8 POLYMYOSITIS 191 0.1516
9 SELF ESTEEM DECREASED 186 0.1442
See all enriched reactions for HMG-CoA Reductase Inhibitor [EPC]